nach oben

Archives of Orthopaedic and Trauma Surgery

Erschienen in:

01.02.2013 | Orthopaedic Surgery

Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes

verfasst von: Angad Malhotra, Matthew H. Pelletier, Yan Yu, William R. Walsh

Erschienen in: Archives of Orthopaedic and Trauma Surgery | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The increased concentration of platelets within platelet-rich plasma (PRP) provides a vehicle to deliver supra-physiologic concentrations of growth factors to an injury site, possibly accelerating or otherwise improving connective tissue regeneration. This potential benefit has led to the application of PRP in several applications; however, inconsistent results have limited widespread adoption in bone healing. This review provides a core understanding of the bone healing mechanisms, and corresponds this to the factors present in PRP. In addition, the current state of the art of PRP preparation, the key aspects that may influence its effectiveness, and treatment outcomes as they relate specifically to bone defect healing are presented. Although PRP does have a sound scientific basis, its use for bone healing appears only beneficial when used in combination with osteoconductive scaffolds; however, neither allograft nor autograft appear to be appropriate carriers. Aggressive processing techniques and very high concentrations of PRP may not improve healing outcomes. Moreover, many other variables exist in PRP preparation and use that influence its efficacy; the effect of these variables should be understood when considering PRP use. This review includes the essentials of what has been established, what is currently missing in the literature, and recommendations for future directions.

Novicoff WM, Manaswi A, Hogan MV, Brubaker SM, Mihalko WM, Saleh KJ (2008) Critical analysis of the evidence for current technologies in bone-healing and repair. J Bone Joint Surg Am 90(Suppl 1):85–91. doi:10.2106/JBJS.G.01521 PubMedCrossRef

Pape HC, Evans A, Kobbe P (2010) Autologous bone graft: properties and techniques. J Orthop Trauma 24(Suppl 1):S36–S40. doi:10.1097/BOT.0b013e3181cec4a1 PubMedCrossRef

Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (6):638–646 (pii:S1079-2104(98)90029-4)

Anitua E, Sanchez M, Orive G, Andia I (2009) Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A 90(4):1262–1263. doi:10.1002/jbm.a.32143 PubMed

Ehrenfest DM, Bielecki T, Del Corso M, Inchingolo F, Sammartino G (2010) Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet–leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A 95(4):1280–1282. doi:10.1002/jbm.a.32894

Mora R, Pedrotti L, Battista Galli G (2006) Failure of Union. Nonunion of the long bones: diagnosis and treatment with compression: distraction techniques. Springer, Italy

Marsell R, Einhorn TA (2010) Emerging bone healing therapies. J Orthop Trauma 24(Suppl 1):S4–S8. doi:10.1097/BOT.0b013e3181ca3fab PubMedCrossRef

Einhorn TA (2005) The science of fracture healing. J Orthop Trauma 19(10 Suppl):S4–S6PubMedCrossRef

Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, Perka C, Buttgereit F, Duda GN (2010) The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev 16(4):427–434. doi:10.1089/ten.TEB.2009.0687 PubMedCrossRef

10.

Mountziaris PM, Mikos AG (2008) Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14(2):179–186. doi:10.1089/ten.teb.2008.0038 PubMedCrossRef

11.

Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A (6):1032–1044

12.

Gaston MS, Simpson AH (2007) Inhibition of fracture healing. J Bone Joint Surg Br 89(12):1553–1560. doi:10.1302/0301-620X.89B12.19671 PubMedCrossRef

13.

Thon JN, Italiano JE (2010) Platelet formation. Seminars Hematol 47(3):220–226. doi:10.1053/j.seminhematol.2010.03.005 CrossRef

14.

Blair P, Flaumenhaft R (2009) Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23(4):177–189. doi:10.1016/j.blre.2009.04.001 PubMedCrossRef

15.

Whiteheart SW (2011) Platelet granules: surprise packages. Blood 118(5):1190–1191. doi:10.1182/blood-2011-06-359836 PubMedCrossRef

16.

Rendu F, Brohard-Bohn B (2001) The platelet release reaction: granules’ constituents, secretion and functions. Platelets 12(5):261–273. doi:10.1080/09537100120068170 PubMedCrossRef

17.

LeBaron RG, Athanasiou KA (2000) Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng 6(2):85–103. doi:10.1089/107632700320720 PubMedCrossRef

18.

Kempen DH, Creemers LB, Alblas J, Lu L, Verbout AJ, Yaszemski MJ, Dhert WJ (2010) Growth factor interactions in bone regeneration. Tissue Eng Part B Rev 16(6):551–566. doi:10.1089/ten.teb.2010.0176 PubMedCrossRef

19.

Perrault R, Wright B, Storie B, Hatherell A, Zahradka P (2011) Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor. Cell Signal 23(4):739–746. doi:10.1016/j.cellsig.2010.12.008 PubMedCrossRef

20.

Kawabata M, Imamura T, Miyazono K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9(1):49–61PubMedCrossRef

21.

Bolsover SR, Hyams JS, Shephard EA, White HA, Wiedemann CG (2004) Intracellular Signaling. In: Cell Biology. Wiley, pp 341–362. doi:10.1002/047146158X.ch16

22.

Rasubala L, Yoshikawa H, Nagata K, Iijima T, Ohishi M (2003) Platelet-derived growth factor and bone morphogenetic protein in the healing of mandibular fractures in rats. The British journal of oral & maxillofacial surgery 41(3):173–178CrossRef

23.

Ross R (1987) Platelet-derived growth factor. Ann Rev Med 38:71–79. doi:10.1146/annurev.me.38.020187.000443 PubMedCrossRef

24.

Fujii H, Kitazawa R, Maeda S, Mizuno K, Kitazawa S (1999) Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. Histochem Cell Biol 112(2):131–138PubMedCrossRef

25.

Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M (1994) PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 125(4):917–928PubMedCrossRef

26.

Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79(4):1283–1316PubMed

27.

Caplan AI, Correa D (2011) PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res 29(12):1795–1803. doi:10.1002/jor.21462 PubMedCrossRef

28.

Hart CE, Bailey M, Curtis DA, Osborn S, Raines E, Ross R, Forstrom JW (1990) Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 29(1):166–172PubMedCrossRef

29.

Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267(16):10931–10934PubMed

30.

Bauer SM, Bauer RJ, Velazquez OC (2005) Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovascular Surg 39(4):293–306PubMedCrossRef

31.

Harmey JH (2004) VEGF and Cancer. Kluwer Academic/Plenum Publishers, New YorkCrossRef

32.

Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5(6):623–628. doi:10.1038/9467 PubMedCrossRef

33.

Maloney JP, Silliman CC, Ambruso DR, Jun Wang RMT, Voelkel NF (1998) In vitro release of vascular endothelial growth factor during platelet aggregation Am J Physiol Heart Circ Physiol 275 (3):1054–1061

34.

Battinelli EM, Markens BA, Italiano JE Jr (2011) Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 118(5):1359–1369. doi:10.1182/blood-2011-02-334524 PubMedCrossRef

35.

Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111(3):1227–1233. doi:10.1182/blood-2007-09-113837 PubMedCrossRef

36.

Sulpice E, Ding S, Muscatelli-Groux B, Berge M, Han ZC, Plouet J, Tobelem G, Merkulova-Rainon T (2009) Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol cell/Auspices Eur Cell Biol Organ 101(9):525–539. doi:10.1042/BC20080221

37.

Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, Schwall R, Ferrara N, Gerritsen ME (2001) Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 158(3):1111–1120. doi:10.1016/S0002-9440(10)64058-8 PubMedCrossRef

38.

Wen Q, Zhou L, Zhou C, Zhou M, Luo W, Ma L (2011) Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration [Abstract]. J Cell Mol Med. doi:10.1111/j.1582-4934.2011.01407.x

39.

Imai Y, Terai H, Nomura-Furuwatari C, Mizuno S, Matsumoto K, Nakamura T, Takaoka K (2005) Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20(10):1723–1730. doi:10.1359/JBMR.050607 CrossRef

40.

Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390(6659):465–471. doi:10.1038/37284 PubMedCrossRef

41.

Patil AS, Sable RB, Kothari RM (2011) An update on transforming growth factor-beta (TGF-beta): sources, types, functions and clinical applicability for cartilage/bone healing. J Cell Physiol. doi:10.1002/jcp.22698

42.

Joyce ME, Roberts AB, Sporn MB, Bolander ME (1990) Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110(6):2195–2207PubMedCrossRef

43.

Horner A, Kemp P, Summers C, Bord S, Bishop NJ, Kelsall AW, Coleman N, Compston JE (1998) Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 23(2):95–102PubMedCrossRef

44.

Yu Y, Yang JL, Chapman-Sheath PJ, Walsh WR (2002) TGF-beta, BMPs, and their signal transducing mediators, Smads, in rat fracture healing. J Biomed Mater Res 60(3):392–397PubMedCrossRef

45.

Zhao L, Jiang S, Hantash BM (2010) Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue Eng Part A 16(2):725–733. doi:10.1089/ten.TEA.2009.0495 PubMedCrossRef

46.

Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112(2):295–307. doi:10.1182/blood-2007-07-103697 PubMedCrossRef

47.

Houde N, Chamoux E, Bisson M, Roux S (2009) Transforming growth factor-beta1 (TGF-beta1) induces human osteoclast apoptosis by up-regulating Bim. J Biol Chem 284(35):23397–23404. doi:10.1074/jbc.M109.019372 PubMedCrossRef

48.

Cho TJ, Gerstenfeld LC, Einhorn TA (2002) Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res Official J Am Soc Bone Miner Res 17(3):513–520. doi:10.1359/jbmr.2002.17.3.513 CrossRef

49.

Urist MR (1965) Bone: formation by autoinduction. Science 150(698):893–899PubMedCrossRef

50.

Schmitt JM, Hwang K, Winn SR, Hollinger JO (1999) Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17(2):269–278. doi:10.1002/jor.1100170217 PubMedCrossRef

51.

Kaipel M, Schutzenberger S, Schultz A, Ferguson J, Slezak P, Morton TJ, Van Griensven M, Redl H (2012) BMP-2 but not VEGF or PDGF in fibrin matrix supports bone healing in a delayed-union rat model. J Orthop Res. doi:10.1002/jor.22132 PubMed

52.

Sakou T (1998) Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22(6):591–603PubMedCrossRef

53.

Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A (8):1544–1552

54.

Kalen A, Wahlstrom O, Linder CH, Magnusson P (2008) The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors. Biochem Biophys Res Commun 375(2):261–264. doi:10.1016/j.bbrc.2008.08.014 PubMedCrossRef

55.

Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62 (4):489–496 (pii: S0278239103012722)

56.

Wahlstrom O, Linder C, Kalen A, Magnusson P (2008) Acidic preparations of platelet concentrates release bone morphogenetic protein-2. Acta Orthop 79(3):433–437. doi:10.1080/17453670710015364 PubMedCrossRef

57.

Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79(12):1778–1790PubMed

58.

Swiontkowski MF, Aro HT, Donell S, Esterhai JL, Goulet J, Jones A, Kregor PJ, Nordsletten L, Paiement G, Patel A (2006) Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88(6):1258–1265. doi:10.2106/JBJS.E.00499 PubMedCrossRef

59.

Fei Y, Xiao L, Doetschman T, Coffin DJ, Hurley MM (2011) Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway. J Biol Chem 286(47):40575–40583. doi:10.1074/jbc.M111.274910 PubMedCrossRef

60.

Tavakoli K, Yu Y, Shahidi S, Bonar F, Walsh WR, Poole MD (1999) Expression of growth factors in the mandibular distraction zone: a sheep study. Br J Plast Surg 52(6):434–439. doi:10.1054/bjps.1999.3157 PubMedCrossRef

61.

Nakajima A, Nakajima F, Shimizu S, Ogasawara A, Wanaka A, Moriya H, Einhorn TA, Yamazaki M (2001) Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat. Bone 29(5):458–466PubMedCrossRef

62.

Marie PJ, Miraoui H, Severe N (2012) FGF/FGFR signaling in bone formation: progress and perspectives. Growth Factors. doi:10.3109/08977194.2012.656761 PubMed

63.

Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8(3):235–253. doi:10.1038/nrd2792 PubMedCrossRef

64.

Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453(7193):314–321. doi:10.1038/nature07039 PubMedCrossRef

65.

Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92 (9 Suppl):II365–371

66.

Willems WF, Larsen M, Giusti G, Friedrich PF, Bishop AT (2011) Revascularization and bone remodeling of frozen allografts stimulated by intramedullary sustained delivery of FGF-2 and VEGF. J Orthop Res 29(9):1431–1436. doi:10.1002/jor.21338 PubMedCrossRef

67.

Fisher MC, Meyer C, Garber G, Dealy CN (2005) Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone 37(6):741–750. doi:10.1016/j.bone.2005.07.024 PubMedCrossRef

68.

Zhou FH, Foster BK, Sander G, Xian CJ (2004) Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats. Bone 35(6):1307–1315. doi:10.1016/j.bone.2004.09.014 PubMedCrossRef

69.

Clark RA (2001) Fibrin and wound healing. Ann N Y Acad Sci 936:355–367PubMedCrossRef

70.

Laurens N, Koolwijk P, de Maat MP (2006) Fibrin structure and wound healing. J Thromb Haemost 4(5):932–939. doi:10.1111/j.1538-7836.2006.01861.x PubMedCrossRef

71.

Jacek H (1989) [15] Platelet secretory pathways: an overview. In: Methods in Enzymology, vol Volume 169. Academic Press, pp 191–195. doi:10.1016/0076-6879(89)69059-3

72.

Santos-Martínez MJ, Medina C, Jurasz P, Radomski MW (2008) Role of metalloproteinases in platelet function. Thrombosis Res 121(4):535–542. doi:10.1016/j.thromres.2007.06.002 CrossRef

73.

Marzona L, Pavolini B (2009) Play and players in bone fracture healing match. Clin Cases Mineral Bone Metabolism 6(2):159–162

74.

Phillips AM (2005) Overview of the fracture healing cascade. Injury 36(Suppl 3):S5–S7. doi:10.1016/j.injury.2005.07.027 PubMedCrossRef

75.

Alsousou J, Thompson M, Hulley P, Noble A, Willett K (2009) The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91(8):987–996. doi:10.1302/0301-620X.91B8.22546 PubMedCrossRef

76.

Lee FY, Choi YW, Behrens FF, DeFouw DO, Einhorn TA (1998) Programmed removal of chondrocytes during endochondral fracture healing. J Orthop Res 16(1):144–150. doi:10.1002/jor.1100160124 PubMedCrossRef

77.

Gutwald R, Haberstroh J, Stricker A, Ruther E, Otto F, Xavier SP, Oshima T, Marukawa E, Seto I, Enomoto S, Hoogendijk CF, Schmelzeisen R, Sauerbier S (2010) Influence of rhBMP-2 on bone formation and osseointegration in different implant systems after sinus-floor elevation. An in vivo study on sheep. J Craniomaxillofac Surg. doi:10.1016/j.jcms.2010.02.010

78.

Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM (2004) Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 22(1):58–65. doi:10.1016/S0736-0266(03)00127-X PubMedCrossRef

79.

Schutzenberger S, Schultz A, Hausner T, Hopf R, Zanoni G, Morton T, Kropik K, van Griensven M, Redl H (2012) The optimal carrier for BMP-2: a comparison of collagen versus fibrin matrix. Archives Orthop Trauma Surg 132(9):1363–1370. doi:10.1007/s00402-012-1551-2 CrossRef

80.

Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A (2006) Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88(7):1431–1441. doi:10.2106/JBJS.E.00381 PubMedCrossRef

81.

Aro HT, Govender S, Patel AD, Hernigou P, de Gregorio AP, Popescu GI, Golden JD, Christensen J, Valentin A (2011) Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am 93(9):801–808. doi:10.2106/JBJS.I.01763 PubMedCrossRef

82.

Seeherman HJ, Li XJ, Bouxsein ML, Wozney JM (2010) rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. J Bone Joint Surg Am 92(2):411–426. doi:10.2106/JBJS.H.01732 PubMedCrossRef

83.

Moore DC, Ehrlich MG, McAllister SC, Machan JT, Hart CE, Voigt C, Lesieur-Brooks AM, Weber EW (2009) Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am 91(8):1973–1984. doi:10.2106/JBJS.H.00540 PubMedCrossRef

84.

Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ (1994) Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15(2):203–208PubMedCrossRef

85.

Solchaga LA, Hee CK, Aguiar DJ, Ratliff J, Turner AS, Seim HB, 3rd, Hollinger JO, Snel LB, Lynch SE (2012) Augment bone graft products compare favorably with autologous bone graft in an ovine model of lumbar interbody spine fusion. Spine (Phila Pa 1976) 37 (8):E461–467. doi:10.1097/BRS.0b013e31823b01dc

86.

Hollinger JO, Onikepe AO, MacKrell J, Einhorn T, Bradica G, Lynch S, Hart CE (2008) Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26(1):83–90. doi:10.1002/jor.20453 PubMedCrossRef

87.

Brennan M (1991) Fibrin glue. Blood Rev 5(4):240–244PubMedCrossRef

88.

Tayapongsak P, O’Brien DA, Monteiro CB, Arceo-Diaz LY (1994) Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow. J Oral Maxillofac Surg 52 (2):161–165; discussion 166

89.

Anitua E (1999) Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 14(4):529–535PubMed

90.

Landesberg R, Roy M, Glickman RS (2000) Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 58 (3):297–300; discussion 300–291 (pii:S0278-2391(00)90058-2)

91.

Kassolis JD, Rosen PS, Reynolds MA (2000) Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Periodontol 71(10):1654–1661. doi:10.1902/jop.2000.71.10.1654 PubMedCrossRef

92.

Borrione P, Gianfrancesco AD, Pereira MT, Pigozzi F (2010) Platelet-rich plasma in muscle healing. Am J Phys Med Rehabil 89(10):854–861. doi:10.1097/PHM.0b013e3181f1c1c7 PubMedCrossRef

93.

de Vos RJ, van Veldhoven PL, Moen MH, Weir A, Tol JL, Maffulli N (2010) Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull 95:63–77. doi:10.1093/bmb/ldq006 PubMedCrossRef

94.

Cervelli V, Gentile P, Scioli MG, Grimaldi M, Casciani CU, Spagnoli LG, Orlandi A (2009) Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods 15(4):625–634. doi:10.1089/ten.TEC.2008.0518 PubMedCrossRef

95.

Man D, Plosker H, Winland-Brown JE (2001) The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 107:229–237

96.

Pallua N, Wolter T, Markowicz M (2010) Platelet-rich plasma in burns. Burns 36(1):4–8. doi:10.1016/j.burns.2009.05.002 PubMedCrossRef

97.

Ding XG, Li SW, Zheng XM, Hu LQ, Hu WL, Luo Y (2009) The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl 11(2):215–221. doi:10.1038/aja.2008.37 PubMedCrossRef

98.

Shen YX, Fan ZH, Zhao JG, Zhang P (2009) The application of platelet-rich plasma may be a novel treatment for central nervous system diseases. Med Hypotheses 73(6):1038–1040. doi:10.1016/j.mehy.2009.05.021 PubMedCrossRef

99.

Villela DL, Santos VL (2010) Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 28(2):111–116. doi:10.3109/08977190903468185 PubMedCrossRef

100.

May JA, Heptinstall S (2004) Effects of anticoagulants used during blood collection on human platelet function. Methods Mol Biol 272:3–11. doi:10.1385/1-59259-782-3:003 PubMed

101.

Pignatelli P, Pulcinelli FM, Ciatti F, Pesciotti M, Sebastiani S, Ferroni P, Gazzaniga PP (1995) Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation. J Clin Lab Anal 9(2):138–140PubMedCrossRef

102.

Araki J, Jona M, Eto H, Aoi N, Kato H, Suga H, Doi K, Yatomi Y, Yoshimura K (2011) Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods. doi:10.1089/ten.TEC.2011.0308 PubMed

103.

White JG (2000) EDTA-induced changes in platelet structure and function: clot retraction. Platelets 11(1):49–55PubMedCrossRef

104.

Zimmermann R, Reske S, Metzler P, Schlegel A, Ringwald J, Eckstein R (2008) Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis. Vox Sang 95(1):20–25. doi:10.1111/j.1423-0410.2008.01062.x PubMedCrossRef

105.

Everts PA, Brown Mahoney C, Hoffmann JJ, Schonberger JP, Box HA, van Zundert A, Knape JT (2006) Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 24(3):165–171. doi:10.1080/08977190600821327 PubMedCrossRef

106.

Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10(4):225–228PubMedCrossRef

107.

Kaux JF, Le Goff C, Renouf J, Peters P, Lutteri L, Gothot A, Crielaard JM (2010) Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS II and GPS III systems. Pathologie-biologie. doi:10.1016/j.patbio.2010.11.002 PubMed

108.

Castillo TN, Pouliot MA, Kim HJ, Dragoo JL (2011) Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 39(2):266–271. doi:10.1177/0363546510387517 PubMedCrossRef

109.

Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167. doi:10.1016/j.tibtech.2008.11.009 PubMedCrossRef

110.

Mehta S, Watson JT (2008) Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 22(6):432–438. doi:10.1097/BOT.0b013e31817e793f PubMedCrossRef

111.

Dugrillon A, Eichler H, Kern S, Kluter H (2002) Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31(6):615–619. doi:10.1054/ijom.2002.0322 PubMedCrossRef

112.

Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE (2004) Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 34(4):665–671. doi:10.1016/j.bone.2003.12.010 PubMedCrossRef

113.

Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M (2006) The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 17(2):212–219. doi:10.1111/j.1600-0501.2005.01203.x PubMedCrossRef

114.

Nikolidakis D, Jansen JA (2008) The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev 14(3):249–258. doi:10.1089/ten.teb.2008.0062 PubMedCrossRef

115.

Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH (2001) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233(1):88–96PubMedCrossRef

116.

Nagata MJ, Messora M, Pola N, Campos N, Vieira R, Esper LA, Sbrana M, Fucini S, Garcia V, Bosco A (2010) Influence of the ratio of particulate autogenous bone graft/platelet-rich plasma on bone healing in critical-size defects: a histologic and histometric study in rat calvaria. J Orthop Res 28(4):468–473. doi:10.1002/jor.21027 PubMed

117.

Wolberg AS (2007) Thrombin generation and fibrin clot structure. Blood Rev 21(3):131–142. doi:10.1016/j.blre.2006.11.001 PubMedCrossRef

118.

Weisel JW (2007) Structure of fibrin: impact on clot stability. J Thromb Haemost 5(Suppl 1):116–124. doi:10.1111/j.1538-7836.2007.02504.x PubMedCrossRef

119.

Everts PA, Hoffmann J, Weibrich G, Mahoney CB, Schonberger JP, van Zundert A, Knape JT (2006) Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 16(5):363–368. doi:10.1111/j.1365-3148.2006.00708.x PubMedCrossRef

120.

Cieslik-Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T (2007) Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (3):303–305; author reply 305–306. doi:10.1016/j.tripleo.2006.08.034

121.

Werther K, Christensen IJ, Nielsen HJ (2002) Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 62(5):343–350PubMedCrossRef

122.

Flad HD, Brandt E (2010) Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cell Mol Life Sci. doi:10.1007/s00018-010-0306-x PubMed

123.

Tang YQ, Yeaman MR, Selsted ME (2002) Antimicrobial peptides from human platelets. Infect Immun 70(12):6524–6533PubMedCrossRef

124.

Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ (2008) Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 26(3):404–410. doi:10.1002/jor.20519 PubMedCrossRef

125.

Sanchez M, Anitua E, Orive G, Mujika I, Andia I (2009) Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 39(5):345–354. doi:10.2165/00007256-200939050-00002 PubMedCrossRef

126.

Delong JM, Russell RP, Mazzocca AD (2012) Platelet-rich plasma: the PAW classification system. Arthroscopy 28(7):998–1009. doi:10.1016/j.arthro.2012.04.148 PubMedCrossRef

127.

Langer R, Vacanti JP (1993) Tissue engineering. Science 260(5110):920–926PubMedCrossRef

128.

Hokugo A, Ozeki M, Kawakami O, Sugimoto K, Mushimoto K, Morita S, Tabata Y (2005) Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 11(7–8):1224–1233. doi:10.1089/ten.2005.11.1224 PubMedCrossRef

129.

Zimmermann G, Moghaddam A (2011) Allograft bone matrix versus synthetic bone graft substitutes. Injury. doi:10.1016/j.injury.2011.06.199

130.

Ranly DM, Lohmann CH, Andreacchio D, Boyan BD, Schwartz Z (2007) Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am 89(1):139–147. doi:10.2106/JBJS.F.00388 PubMedCrossRef

131.

Ni M, Tang P, Wang Y, Li G (2011) Experimental study on promoting bone consolidation by using platelet-rich plasma and decalcified bone matrix during distraction osteogenesis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 25(6):661–667PubMed

132.

Myeroff C, Archdeacon M (2011) Autogenous bone graft: donor sites and techniques. J Bone Joint Surg Am 93(23):2227–2236. doi:10.2106/JBJS.J.01513 PubMedCrossRef

133.

Mooren RE, Merkx MA, Bronkhorst EM, Jansen JA, Stoelinga PJ (2007) The effect of platelet-rich plasma on early and late bone healing: an experimental study in goats. Int J Oral Maxillofac Surg 36(7):626–631. doi:10.1016/j.ijom.2007.03.013 PubMedCrossRef

134.

Mooren RE, Dankers AC, Merkx MA, Bronkhorst EM, Jansen JA, Stoelinga PJ (2010) The effect of platelet-rich plasma on early and late bone healing using a mixture of particulate autogenous cancellous bone and Bio-Oss: an experimental study in goats. Int J Oral Maxillofac Surg 39(4):371–378. doi:10.1016/j.ijom.2009.12.019 PubMedCrossRef

135.

Aghaloo TL, Moy PK, Freymiller EG (2002) Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. J Oral Maxillofac Surg 60(10):1176–1181PubMedCrossRef

136.

Dallari D, Fini M, Stagni C, Torricelli P, Nicoli Aldini N, Giavaresi G, Cenni E, Baldini N, Cenacchi A, Bassi A, Giardino R, Fornasari PM, Giunti A (2006) In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 24(5):877–888. doi:10.1002/jor.20112 PubMedCrossRef

137.

Hakimi M, Jungbluth P, Sager M, Betsch M, Herten M, Becker J, Windolf J, Wild M (2010) Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury 41(7):717–723. doi:10.1016/j.injury.2009.12.005 PubMedCrossRef

138.

Walsh WR, Vizesi F, Michael D, Auld J, Langdown A, Oliver R, Yu Y, Irie H, Bruce W (2008) β-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials 29(3):266–271PubMedCrossRef

139.

Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de Ruiter A, Walsh WR, van Blitterswijk CA, de Bruijn JD (2010) Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA 107(31):13614–13619. doi:10.1073/pnas.1003600107 PubMedCrossRef

140.

Kasten P, Vogel J, Geiger F, Niemeyer P, Luginbuhl R, Szalay K (2008) The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29(29):3983–3992. doi:10.1016/j.biomaterials.2008.06.014 PubMedCrossRef

141.

Kanthan SR, Kavitha G, Addi S, Choon DS, Kamarul T (2011) Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: a preliminary study involving rabbit models. Injury 42(8):782–789. doi:10.1016/j.injury.2011.01.015 PubMedCrossRef

142.

Paderni S, Terzi S, Amendola L (2009) Major bone defect treatment with an osteoconductive bone substitute. Musculoskelet Surg 93(2):89–96. doi:10.1007/s12306-009-0028-0 CrossRef

143.

Walsh WR, Loefler A, Nicklin S, Arm D, Stanford RE, Yu Y, Harris R, Gillies RM (2004) Spinal fusion using an autologous growth factor gel and a porous resorbable ceramic. Eur Spine J 13(4):359–366. doi:10.1007/s00586-003-0597-9 PubMedCrossRef

144.

Klein MO, Kammerer PW, Scholz T, Moergel M, Kirchmaier CM, Al-Nawas B (2010) Modulation of platelet activation and initial cytokine release by alloplastic bone substitute materials. Clin Oral Implants Res. doi:10.1111/j.1600-0501.2009.01830.x

145.

Hu ZM, Peel SA, Ho SK, Sandor GK, Clokie CM (2009) Comparison of platelet-rich plasma, bovine BMP, and rhBMP-4 on bone matrix protein expression in vitro. Growth Factors 27(5):280–288. doi:10.1080/08977190903137819 PubMedCrossRef

146.

Roldan JC, Jepsen S, Miller J, Freitag S, Rueger DC, Acil Y, Terheyden H (2004) Bone formation in the presence of platelet-rich plasma versus bone morphogenetic protein-7. Bone 34(1):80–90PubMedCrossRef

147.

Forriol F, Longo UG, Concejo C, Ripalda P, Maffulli N, Denaro V (2009) Platelet-rich plasma, rhOP-1 (rhBMP-7) and frozen rib allograft for the reconstruction of bony mandibular defects in sheep. a pilot experimental study. Injury 40(Suppl 3):S44–S49. doi:10.1016/S0020-1383(09)70011-7 PubMedCrossRef

Titel: Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes
verfasst von: Angad Malhotra
Matthew H. Pelletier
Yan Yu
William R. Walsh
Publikationsdatum: 01.02.2013
Verlag: Springer-Verlag
Erschienen in: Archives of Orthopaedic and Trauma Surgery / Ausgabe 2/2013
Print ISSN: 0936-8051
Elektronische ISSN: 1434-3916
DOI: https://doi.org/10.1007/s00402-012-1641-1

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Results of dynamic pedobarography following surgically treated intra-articular calcaneal fractures

Clinical and radiological outcomes of spinal cord injury without radiologic evidence of trauma with cervical disc herniation

Three to seven year follow-up of a tapered modular femoral prosthesis in revision total hip arthroplasty

Treatment of periprosthetic tibial plateau fractures in unicompartmental knee arthroplasty: plates versus cannulated screws

The importance of CT for the pre-operative surgical planning in recurrent anterior shoulder instability